Advanced bioanalytics for precision medicine
暂无分享,去创建一个
Elisa Michelini | Aldo Roda | Massimo Guardigli | Mara Mirasoli | Cristiana Caliceti | Patrizia Simoni | A. Roda | M. Mirasoli | M. Guardigli | P. Simoni | E. Michelini | C. Caliceti
[1] Daniel Filippini,et al. Towards autonomous lab-on-a-chip devices for cell phone biosensing. , 2016, Biosensors & bioelectronics.
[2] R. Williams,et al. Biochemical Individuality: The Basis for the Genetotrophic Concept , 1957 .
[3] 최영식,et al. [핵심 광 기술소개] MALDI(Matrix - Assisted Laser Desorption / Ionization) 질량분석법 , 2005 .
[4] Joerg M. Buescher,et al. Integration of omics: more than the sum of its parts , 2016, Cancer & Metabolism.
[5] Irene van den Broek,et al. Bioanalytical LC-MS/MS of protein-based biopharmaceuticals. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] Jorge Ripoll,et al. Advances in optical imaging for pharmacological studies , 2015, Front. Pharmacol..
[7] A. Ganser,et al. Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation , 2013, Leukemia.
[8] L. Hood,et al. Predictive, personalized, preventive, participatory (P4) cancer medicine , 2011, Nature Reviews Clinical Oncology.
[9] M. Weale,et al. Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? , 2016, The Pharmacogenomics Journal.
[10] Paola Taroni,et al. Review of optical breast imaging and spectroscopy , 2016, Journal of biomedical optics.
[11] I. Y. Chen,et al. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine , 2016, Nature Reviews Cardiology.
[12] Xueyang Feng,et al. OM-FBA: Integrate Transcriptomics Data with Flux Balance Analysis to Decipher the Cell Metabolism , 2016, PloS one.
[13] U. Sunar,et al. Optical imaging of tissue obtained by transbronchial biopsies of peripheral lung lesions. , 2017, Journal of thoracic disease.
[14] Yun Zhou,et al. Quantitative multimodal multiparametric imaging in Alzheimer’s disease , 2016, Brain Informatics.
[15] Robert Powers,et al. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics. , 2017, Progress in nuclear magnetic resonance spectroscopy.
[16] Midhir J Patel,et al. Role of Imaging in the Era of Precision Medicine. , 2017, Academic radiology.
[17] F. Kiessling,et al. Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. , 2015, Chemical reviews.
[18] M. E. Patterson,et al. A Focus Group Exploration of Automated Case-Finders to Identify High-Risk Heart Failure Patients Within an Urban Safety Net Hospital , 2016, EGEMS.
[19] David E. Fisher,et al. Precision medicine for cancer with next-generation functional diagnostics , 2015, Nature Reviews Cancer.
[20] C. Berking,et al. The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study , 2015, The British journal of dermatology.
[21] Christa M Cobbaert,et al. Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry , 2016, Expert review of proteomics.
[22] B. Turner,et al. Pathologic diagnosis, immunohistochemistry, multigene assays and breast cancer treatment: progress toward “precision” cancer therapy , 2015, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[23] J. Leppert,et al. Perspective: Beyond the genome , 2016, Nature.
[24] Jacqueline A. Hall,et al. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories , 2017, Applied immunohistochemistry & molecular morphology : AIMM.
[25] ping wang,et al. Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer , 2017, Oncotarget.
[26] Tassaneewan Laksanasopin,et al. Point-of-Care Diagnostics: Recent Developments in a Connected Age. , 2017, Analytical chemistry.
[27] Aydogan Ozcan,et al. Mobile Phone-Based Microscopy, Sensing, and Diagnostics , 2016, IEEE Journal of Selected Topics in Quantum Electronics.
[28] Chichung Wang,et al. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. , 2014, Methods.
[29] M. Karas,et al. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.
[30] K. Kelnar,et al. Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer. , 2017, Lung cancer.
[31] Tang Tang,et al. Nanoparticle-based multimodal PET/MRI probes. , 2015, Nanomedicine.
[32] Carmen C. Y. Poon,et al. Big Data for Health , 2015, IEEE Journal of Biomedical and Health Informatics.
[33] Benjamin Balluff,et al. Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations. , 2017, The Analyst.
[34] A. Merkoçi,et al. Mobile phone-based biosensing: An emerging "diagnostic and communication" technology. , 2017, Biosensors & bioelectronics.
[35] L. Pantanowitz,et al. The role of informatics in patient‐centered care and personalized medicine , 2017, Cancer cytopathology.
[36] Chao Zhang,et al. Applications of Mass Spectrometry Imaging to Cancer. , 2017, Advances in cancer research.
[37] C. Printz. Neurotoxicity more likely in Hispanic children treated for acute lymphoblastic leukemia , 2019, Cancer.
[38] Thomas E. Yankeelov,et al. Quantitative multimodality imaging in cancer research and therapy , 2014, Nature Reviews Clinical Oncology.
[39] R. Kittles,et al. Warfarin Pharmacogenomics in Diverse Populations , 2017, Pharmacotherapy.
[40] D. Mankoff,et al. Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review , 2017, JAMA oncology.
[41] D. Wishart. Emerging applications of metabolomics in drug discovery and precision medicine , 2016, Nature Reviews Drug Discovery.
[42] H. Cui,et al. Functional nanoparticles for magnetic resonance imaging. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[43] Gehua Wang,et al. Recent development of mass spectrometry and proteomics applications in identification and typing of bacteria , 2016, Proteomics. Clinical applications.
[44] Kate Grieve,et al. Assessment of Sentinel Node Biopsies With Full-Field Optical Coherence Tomography , 2016, Technology in cancer research & treatment.
[45] M Heath-Chiozzi,et al. Clinical application of pharmacogenetics. , 2001, Trends in molecular medicine.
[46] M. Mann,et al. Electrospray Ionization for Mass Spectrometry of Large Biomolecules , 1990 .
[47] T. Duarte,et al. Personalized Proteomics: The Future of Precision Medicine , 2016, Proteomes.
[48] M. Hutz,et al. Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease. , 2016, Pharmacogenomics.
[49] F. Ghiringhelli,et al. Precision medicine in breast cancer: reality or utopia? , 2017, Journal of Translational Medicine.
[50] Martin Wiedmann,et al. Precision food safety: A systems approach to food safety facilitated by genomics tools , 2017 .
[51] Bruno Domon,et al. Advances in high‐resolution accurate mass spectrometry application to targeted proteomics , 2015, Proteomics.
[52] Karl Garsha,et al. Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies. , 2017, Laboratory investigation; a journal of technical methods and pathology.
[53] Davide Prandi,et al. Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. , 2017, Cancer discovery.
[54] T. Yogo,et al. Relaxometric property of organosilica nanoparticles internally functionalized with iron oxide and fluorescent dye for multimodal imaging. , 2017, Journal of colloid and interface science.
[55] A. Berry. Analytic inquiry: Validation and practical considerations , 2017, Cancer cytopathology.
[56] H. Ryu,et al. Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer , 2017, Scientific Reports.
[57] Shuzhao Li,et al. Blood transcriptomics and metabolomics for personalized medicine , 2015, Computational and structural biotechnology journal.
[58] William B. Bean,et al. Biochemical Individuality: The Basis for the Genetotrophic Concept. , 1957 .
[59] D. Shin,et al. The medicinal chemistry of theragnostics, multimodality imaging and applications of nanotechnology in cancer. , 2010, Current topics in medicinal chemistry.
[60] Alfonso Valencia,et al. Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment , 2014, Clinical Cancer Research.
[61] M O Karlsson,et al. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium , 2017, Clinical pharmacology and therapeutics.
[62] Aldo Roda,et al. Smartphone-based biosensors: A critical review and perspectives , 2016 .
[63] Roberto Rey-Dios,et al. Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies. , 2014, World neurosurgery.
[64] Karen Y He,et al. Big Data Analytics for Genomic Medicine , 2017, International journal of molecular sciences.
[65] S. Basu,et al. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management? , 2016, Cancer biotherapy & radiopharmaceuticals.